ABUS R&D Expense Growth
Arbutus Biopharma Corp · R&D Expense Growth
ABUS R&D Expense Growth
Latest reported-53.29%period ending
ABUS FY R&D Growth (YoY) (0.00% → -53.29%)
Latest values, visible window
High-resolution chart · PNG
ABUS r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -53.2894% | |
| -26.6798% | |
| -12.686% | |
| 28.8632% | |
| 32.7618% | |
| -14.3452% | |
| -0.5164% | |
| -7.6555% | |
| 2.2838% | |
| 19.0176% | |
| 33.0879% | |
| 80.3501% | |
| 18.3876% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| -100% | |
| 86.2719% | |
| -48.3565% | |
| -60.7321% | |
| -5.8609% | |
| 9.7056% | |
| 68.1739% | |
| 47.4183% | |
| 12.5182% | |
| -10.4549% | |
| 0% |